Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMUC | ISIN: SE0015987946 | Ticker-Symbol: 9480
Frankfurt
01.11.24
21:49 Uhr
0,950 Euro
-0,030
-3,06 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SYNTHETICMR AB Chart 1 Jahr
5-Tage-Chart
SYNTHETICMR AB 5-Tage-Chart

Aktuelle News zur SYNTHETICMR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSYNTHETICMR AB: SyntheticMR Receives Regulatory Approval for SyMRI 15 in Australia3
02.10.SyntheticMR AB: SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland254LINKÖPING, Sweden, Oct. 2, 2024 /PRNewswire/ -- SyntheticMR AB, global leader in advanced quantitative imaging software, is pleased to announce that its SyMRI 15 solution has received regulatory...
► Artikel lesen
25.09.SYNTHETICMR AB: SyntheticMR Announces Regulatory Clearance for SyMRI 15 in the UK1
09.09.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 09.09.2024511The following instruments on XETRA do have their first trading 09.09.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.09.2024 Aktien 1 JP3701000006 JCR Pharmaceuticals...
► Artikel lesen
04.09.SYNTHETICMR AB: SyntheticMR Announces the Appointment of Francois Hebert as New President, North America10
27.08.SYNTHETICMR AB: Interim report April - June 20242
19.08.SYNTHETICMR AB: SyntheticMR Receives Regulatory Approval for SyMRI in Taiwan2
09.07.SYNTHETICMR AB: SyntheticMR announces estimated net sales of SEK 12m. (21.2) for quarter 2 of 2024 depending on organizational changes in USA. The net sales target for 2024 is therefore not expected to be achieved4
26.06.SyntheticMR AB: SyMRI 15 by SyntheticMR obtains CE-Marking434SyntheticMR announced today that version 15 of their next-generation imaging solution, SyMRI Neuro, has obtained CE-marking. LINKÖPING, Sweden, June 26, 2024 /PRNewswire/ -- SyMRI...
► Artikel lesen
22.05.Report from Annual General Meeting in SyntheticMR AB (publ)1
21.05.SYNTHETICMR AB: Interim report January - March 20241
01.03.SyntheticMR AB: Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients685LINKÖPING, Sweden, March 1, 2024 /PRNewswire/ -- Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, and magnetic resonance imaging (MRI) software solutions company...
► Artikel lesen
18.12.23SyntheticMR AB: SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking416LINKÖPING, Sweden, Dec. 18, 2023 /PRNewswire/ -- SyntheticMR announced today that their next-generation imaging solution with isotropic 3D resolution, SyMRI 3D, has obtained approval in the...
► Artikel lesen
30.11.23SyntheticMR AB: SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D631LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D. The expanded agreement between...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1